BrioHealth Solutions ( today announces the successful implantation of its 100th BrioVAD System, an investigational ...

Despite major advances in the treatment of heart failure over the past 2 decades improving the natural history of this condition, heart failure continues to be a major source of morbidity and ...

As the med tech industry casts its eye toward next-generation devices for severe cardiac conditions, physicians are weighing in on the products' efficacy in treating patients with heart failure.

Heart failure is one of the most pressing health challenges of our time, affecting over 64 million people worldwide and driving significant mortality, morbidity, and healthcare costs. As donor heart ...

Fueled by increasing heart failure cases, technological innovations, and rising investment in VAD research, projected to grow at a CAGR of 8.8% from 2024-2032. AUSTIN, TX, UNITED STATES, January 30, ...

At any one time in this country 50 to 100,000 people are suffering from heart failure, but only about 2,000 people a year receive heart transplants. For some people, an LVAD device can help patients ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

After receiving only the fourth US implant of a new-generation, Utah-made ventricular assist device, an Idaho man with heart failure is looking forward to resuming an active life following an ...

VADs are usually classified according to the mode of blood flow, namely pulsatile or continuous. Continuous types can be further subdivided based on the biomechanics of the pump: centrifugal or axial.

DUBLIN--(BUSINESS WIRE)--The "North America Ventricular Assist Devices (VADs) Market (2018 - 2024)" report has been added to ResearchAndMarkets.com's offering. Ventricular assist devices are ...

A team led by Children's Hospital Los Angeles has become the first in the world to demonstrate the possibility of using genetically engineered pig hearts as a potential "bridge" to heart transplant ...

Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the late 1980s, major advances have been seen in their ...